SCHEMBL14525219

SCHEMBL14525219

CNC(=O)c1ccc(C)c(NC)n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BRD4 O60885 2/20 0.41
▸ RAB9A P51151 3/20 0.41
▸ NPC1 O15118 2/20 0.41
▸ CNR1 P21554 1/20 0.41
▸ POLB P06746 1/20 0.41
▸ P2RX7 Q99572 1/20 0.40
▸ BAZ2B Q9UIF8 1/20 0.40
▸ SCN10A Q9Y5Y9 2/20 0.39
▸ SCN1A P35498 1/20 0.38
▸ KCNH2 Q12809 1/20 0.38
▸ SCN5A Q14524 1/20 0.38
▸ SCN9A Q15858 1/20 0.38
▸ SCN2A Q99250 1/20 0.38
▸ SCN3A Q9NY46 1/20 0.38
▸ HPGD P15428 2/20 0.38
▸ GRM5 P41594 1/20 0.38
▸ CNR2 P34972 2/20 0.37
▸ GAA P10253 1/20 0.36
▸ NFKB1 P19838 1/20 0.36
▸ NFKB2 Q00653 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5632216 0.83 KDM4E (0.44) RAB9AALDH1A1
SCHEMBL13547615 0.83 SMN1; SMN2 (0.38) RAB9ANPC1P2RX7HPGDGRM5
SCHEMBL14525218 0.81 KIT (0.40) POLBP2RX7CNR2
SCHEMBL25690322 0.81 BRD4 (0.44) BRD4RAB9ANPC1CNR1POLB
SCHEMBL27398469 0.78 SCN10A (0.46) BRD4RAB9ANPC1CNR1POLB
SCHEMBL25690235 0.78 BRD4 (0.41) BRD4RAB9ANPC1CNR1POLB
SCHEMBL21762134 0.75 P2RX7 (0.45) BRD4RAB9ANPC1CNR1POLB
SCHEMBL25690219 0.74 PTPN1 (0.42) BRD4RAB9ANPC1CNR1POLB
SCHEMBL27398471 0.74 PARP1 (0.41) BRD4RAB9ANPC1CNR1POLB
SCHEMBL8300009 0.73 P2RX7 (0.70) BRD4RAB9ANPC1CNR1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7208603-B2 Reducing amination with cyanohydrin PIERRE FABRE MEDICAMENT (FR) 2007-04-24 — — US disclosed
US-7208603-B2 Reducing amination with cyanohydrin PIERRE FABRE MEDICAMENT (FR) 2007-04-24 — — US disclosed
Send feedback